These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1326115)

  • 1. Behavioral effects of centrally administered LH-RH agonist in rats.
    Kádár T; Telegdy G; Schally AV
    Physiol Behav; 1992 Mar; 51(3):601-5. PubMed ID: 1326115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropharmacological actions of the superactive agonist analog D-TRP-6-LH-RH after peripheral injection into mice.
    Kádár T; Telegdy G; Schally AV
    Neuropeptides; 1990 Oct; 17(2):81-6. PubMed ID: 2149170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partial reversal of behavioral action of the agonist D-Trp-6-LH-RH by naloxone in mice.
    Kádár T; Telegdy G; Schally AV
    Life Sci; 1990; 46(7):463-70. PubMed ID: 2137549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An LH-RH antagonist inhibits the behavioral effects of the agonist D-TRP-6-LH-RH in mice.
    Kádár T; Telegdy G; Schally AV
    Pharmacol Biochem Behav; 1992 Apr; 41(4):665-8. PubMed ID: 1594632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of the LH response induced by the agonist D-Trp-6-LHRH in rats by a highly potent LH-RH antagonist SB-75.
    Pinski J; Yano T; Miller G; Schally AV
    Prostate; 1992; 20(3):213-24. PubMed ID: 1533453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of neurotransmitter and neuropeptides in behavioural action of some neurohormones.
    Telegdy G; Kádár T; Balázs M
    Pol J Pharmacol Pharm; 1990; 42(6):537-46. PubMed ID: 1983290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatostatin analogs as adjuncts to agonists of luteinizing hormone-releasing hormone in the treatment of experimental prostate cancer.
    Schally AV; Redding TW
    Proc Natl Acad Sci U S A; 1987 Oct; 84(20):7275-9. PubMed ID: 2890164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regression of nitrosamine-induced pancreatic cancers in hamsters treated with luteinizing hormone-releasing hormone antagonists or agonists.
    Szende B; Srkalovic G; Groot K; Lapis K; Schally AV
    Cancer Res; 1990 Jun; 50(12):3716-21. PubMed ID: 2160323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effects of analogs of luteinizing hormone-releasing hormone against x-radiation-induced testicular damage in rats.
    Schally AV; Paz-Bouza JI; Schlosser JV; Karashima T; Debeljuk L; Gandle B; Sampson M
    Proc Natl Acad Sci U S A; 1987 Feb; 84(3):851-5. PubMed ID: 2949328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effects of analogs of luteinizing hormone-releasing hormone against chemotherapy-induced testicular damage in rats.
    Karashima T; Zalatnai A; Schally AV
    Proc Natl Acad Sci U S A; 1988 Apr; 85(7):2329-33. PubMed ID: 2965391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of growth of a prolactin-secreting pituitary tumor in rats by analogs of luteinizing hormone-releasing hormone and somatostatin.
    de Quijada MG; Redding TW; Coy DH; Torres-Aleman I; Schally AV
    Proc Natl Acad Sci U S A; 1983 Jun; 80(11):3485-8. PubMed ID: 6134284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of mammary tumor growth in rats and mice by administration of agonistic and antagonistic analogs of luteinizing hormone-releasing hormone.
    Redding TW; Schally AV
    Proc Natl Acad Sci U S A; 1983 Mar; 80(5):1459-62. PubMed ID: 6219395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of a long-acting delivery system for luteinizing hormone-releasing hormone agonist with Novantrone chemotherapy: increased efficacy in the rat prostate cancer model.
    Schally AV; Kook AI; Monje E; Redding TW; Paz-Bouza JI
    Proc Natl Acad Sci U S A; 1986 Nov; 83(22):8764-8. PubMed ID: 2946045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. D-Tryptophan-6 analog of luteinizing hormone-releasing hormone as a protective agent against testicular damage caused by cyclophosphamide in baboons.
    Lewis RW; Dowling KJ; Schally AV
    Proc Natl Acad Sci U S A; 1985 May; 82(9):2975-9. PubMed ID: 3157995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effects of analogs of luteinizing hormone-releasing hormone on the growth of the androgen-independent Dunning R-3327-AT-1 rat prostate cancer.
    Pinski J; Reile H; Halmos G; Groot K; Schally AV
    Int J Cancer; 1994 Oct; 59(1):51-5. PubMed ID: 7927904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of experimental ovarian carcinoma with monthly injection of the agonist D-Trp-6-LH-RH: a preliminary report.
    Pour PM; Redding TW; Paz-Bouza JI; Schally AV
    Cancer Lett; 1988 Jul; 41(1):105-10. PubMed ID: 2968836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radioimmunoassay for 6-D-tryptophan analog of luteinizing hormone-releasing hormone: measurement of serum levels after administration of long-acting microcapsule formulations.
    Mason-Garcia M; Vigh S; Comaru-Schally AM; Redding TW; Somogyvari-Vigh A; Horvath J; Schally AV
    Proc Natl Acad Sci U S A; 1985 Mar; 82(5):1547-51. PubMed ID: 3156381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effects of analogs of luteinizing hormone-releasing hormone and somatostatin on pancreatic cancers in hamsters. Events that accompany tumor regression.
    Szende B; Srkalovic G; Schally AV; Lapis K; Groot K
    Cancer; 1990 May; 65(10):2279-90. PubMed ID: 1971771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effect of a highly potent antagonist of LH releasing hormone (SB-75) on the pituitary gonadal axis in the intact and castrated rat.
    Ayalon D; Farhi Y; Comaru-Schally AM; Schally AV; Eckstein N; Vagman I; Limor R
    Neuroendocrinology; 1993 Aug; 58(2):153-9. PubMed ID: 8264861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in the 32P incorporation in rat mammary tumor after chronic administration of LH-RH analogs.
    Cehovic G; Redding TW; Schally AV
    Med Oncol Tumor Pharmacother; 1985; 2(4):243-7. PubMed ID: 2935686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.